Search

everythinglearnresearchcommunity

for

Search:↓

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

Finasteride and dutasteride can cause sexual problems like impotence and low libido.

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Hand preference and sexual orientation may predict finasteride side effects in male hair loss.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Stromal Vascular Fraction might help with male sexual dysfunction, but more research is needed to confirm its safety and effectiveness.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Adolescents and young adults with Prader-Willi syndrome show a range of sexual interests and behaviors.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Finasteride, a hair loss drug, may cause sexual dysfunction and depression, but these effects are usually temporary and the drug is generally safe. More research is needed.

Testosterone replacement therapy significantly improved sexual interest and function in HIV+ men.

Dutasteride is linked to a higher chance of sexual dysfunction, especially in younger males and the elderly.

Male tissue has more cell death than female tissue after ischemia, and some neurosteroids only protect female cells.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Young men with mild hair loss who experience significant social and emotional distress are more likely to have sexual problems.

Finasteride use in young men with hair loss is linked to sexual dysfunction.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Finasteride may cause lasting sexual side effects, but more research is needed.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

Childhood sexual trauma, especially between ages 5-7, is linked to lower cortisol levels in adult hair, suggesting long-term stress response changes.

Finasteride use may cause sexual dysfunction; more research needed.

Married Egyptian women with PCOS have lower sexual desire compared to those without PCOS.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

PCOS increases sexual pain distress in infertile women.